Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults

Last updated: July 29, 2015
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Overall Status: Completed

Phase

N/A

Condition

Scar Tissue

Cystic Fibrosis

Lung Disease

Treatment

N/A

Clinical Study ID

NCT02368080
StLuc MBWN2 01
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study compares the lung clearance index (LCI) in cystic fibrosis and healthy adults obtained with two different multiple breath nitrogen washout (MBWN2) devices. Each participants will perform the test (LCI) in duplicate on each device.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Cystic fibrosis diagnosis

Exclusion

Exclusion Criteria:

  • Respiratory infection within 3 weeks

  • Chronically infected with methicillin-resistant Staphylococcus aureus or BurkholderiaCepacia

Study Design

Total Participants: 95
Study Start date:
April 01, 2013
Estimated Completion Date:
January 31, 2014

Study Description

Using nitrogen as the inert gas, there are currently two commercially available devices that offer the possibility to measure the LCI. However, comparison between them are lacking. The 2 MBWN2 devices are the "EasyOne Pro Lab" (ndd Medical Technologies, Zürich, Switzerland) and the "Exhalyzer D" (Eco Medics AG, Duernten, Switzerland).

Connect with a study center

  • Cliniques universitaires Saint-Luc

    Brussels, 1200
    Belgium

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.